Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06504199
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-10
Brief Title:
Obinutuzumab Zanubrutinib and Lenalidomide Followed Short-Cycle of Obinutuzumab and Cytarabine in Newly Diagnosed Mantle Cell Lymphoma
Sponsor:
Organization:
None